A Revolutionary Device for Assessing Blood Flow in Sepsis Patients
A nurse at El Camino Health in Mountain View, California, recently demonstrated the FloPatch device, which has been approved by the Food and Drug Administration. This cutting-edge device is designed to address the problem of sepsis, an overreactive immune response to infection that can be fatal.
Once placed on the patient’s neck, the FloPatch device monitors blood flow in the carotid arteries and wirelessly transmits real-time data to a secure mobile application. This data provides clinicians with crucial information to better diagnose and treat sepsis.
According to the Centers for Disease Control and Prevention (CDC), sepsis is a life-threatening condition that affects over 1.7 million Americans each year, resulting in approximately 350,000 deaths. Prompt diagnosis and appropriate treatment, including the administration of antibiotics, are vital for saving lives.
Recognizing the challenges in identifying and treating sepsis, hospitals and research institutions are developing innovative solutions. El Camino Health, for instance, has been utilizing the FloPatch device since March and has successfully monitored blood flow in over 230 sepsis patients.
Dr. Chaz Langelier from the University of California-San Francisco highlights the importance of precision medicine tools in identifying the microbes causing sepsis. This enables a better understanding of the dysregulated immune responses and aids in the development of more effective treatments.
While anyone can be affected by sepsis, certain individuals, such as those with weakened immune systems, chronic infections, and multiple medical problems, are at a higher risk. Prompt diagnosis and treatment are essential because sepsis impairs vital organ function and can lead to tissue damage.
Hospitals like Northwestern Medicine Delnor Hospital in Geneva, Illinois, and Yale School of Medicine are implementing strategies to improve sepsis management. Delnor Hospital utilizes an algorithm integrated into the electronic medical record system to alert clinicians of potential sepsis cases, enabling early identification and treatment. Yale School of Medicine is evaluating software that tracks vital signs and employs real-time analytics to detect early signs of sepsis.
With the advancements in technology and the support of innovative approaches, healthcare providers are optimistic about improving sepsis outcomes. Real-time analytics, machine learning, and artificial intelligence have the potential to revolutionize sepsis management and save more lives.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
